SCHEMBL3847529

SCHEMBL3847529

Cc1cn(-c2ncnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4c(F)cccc4F)cc23)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 14/20 0.40
CYP1A2 P05177 13/20 0.40
ALDH1A1 P00352 12/20 0.40
CYP2C19 P33261 11/20 0.40
CLK4 Q9HAZ1 10/20 0.40
LMNA P02545 9/20 0.40
CYP2D6 P10635 5/20 0.40
HSD17B10 Q99714 4/20 0.40
TP53 P04637 4/20 0.40
ALOX15 P16050 2/20 0.40
CYP2C9 P11712 1/20 0.40
MAP4K4 O95819 1/20 0.35
HIF1A Q16665 8/20 0.35
TSHR P16473 7/20 0.35
MAPK1 P28482 7/20 0.35
MEN1 O00255 6/20 0.35
KMT2A Q03164 6/20 0.35
USP2 O75604 5/20 0.35
TGFBR1 P36897 2/20 0.34
HPGD P15428 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846896 0.86 CYP3A4 (0.36) CYP3A4CYP1A2ALDH1A1CYP2C19CLK4
SCHEMBL3846604 0.84 MAP4K4 (0.35) CYP3A4CYP1A2ALDH1A1CYP2C19CLK4
SCHEMBL3844886 0.81 MAP4K4 (0.36) CYP3A4CYP1A2ALDH1A1CYP2C19CLK4
SCHEMBL3850082 0.79 CYP1A2 (0.42) CYP3A4CYP1A2ALDH1A1CYP2C19CLK4
SCHEMBL3848884 0.79 EGFR (0.39) CYP3A4CYP1A2ALDH1A1CYP2C19CYP2D6
SCHEMBL3845615 0.76 MAP4K4 (0.33) CYP3A4CYP1A2ALDH1A1CYP2C19CLK4
SCHEMBL3846029 0.76 MAP4K4 (0.33) MAP4K4RAF1BRAF
SCHEMBL3847718 0.75 MAPK14 (0.46) ALDH1A1CYP2D6TP53TGFBR1HPGD
SCHEMBL3845778 0.74 MAP4K4 (0.32) CYP3A4CYP1A2CYP2C19CLK4LMNA
SCHEMBL3847727 0.73 PIK3CD (0.41) CYP3A4CYP1A2ALDH1A1CYP2C19CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed